Penile calciphylaxis in patients with end‐stage kidney disease undergoing dialysis: Invasive treatment and pain management
暂无分享,去创建一个
Y. Kawai | Tomoyasu Sato | H. Kawanishi | M. Banshodani | M. Moriishi | S. Shintaku | T. Masaki | Hiroko Shizukawa
[1] M. Solberg,et al. Comparison of two behavioural pain scales for the assessment of procedural pain: A systematic review , 2020, Nursing open.
[2] Jessica Tullington,et al. Lower Genitourinary Trauma , 2020 .
[3] Y. Wada,et al. Multidisciplinary management of calciphylaxis: a series of 5 patients at a single facility , 2019, CEN Case Reports.
[4] J. Hoenderop,et al. Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation , 2018, Scientific Reports.
[5] A. Chiu,et al. Penile Calciphylaxis in a Patient with End-stage Renal Disease: A Case Report and Review of the Literature , 2018, Open medicine.
[6] M. Uematsu,et al. Usefulness of Endovascular Therapy for Penile Gangrene Secondary to Calciphylaxis: A Case Report. , 2015, Annals of vascular surgery.
[7] P. Parfrey,et al. The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[8] Paul Buttes,et al. Validation of the Critical-Care Pain Observation Tool in Adult Critically Ill Patients , 2014, Dimensions of critical care nursing : DCCN.
[9] T. Miyata,et al. Revascularization surgery for penile calciphylaxis. , 2013, Journal of Vascular Surgery.
[10] R. Vleugels,et al. Calciphylaxis: a systematic review of existing and emerging therapies. , 2012, Journal of the American Academy of Dermatology.
[11] F. Kirçelli,et al. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] M. Pittelkow,et al. Calciphylaxis: natural history, risk factor analysis, and outcome. , 2007, Journal of the American Academy of Dermatology.
[13] Yasushi Tanaka,et al. Penile necrosis by calciphylaxis in a diabetic patient with chronic renal failure. , 2007, Internal medicine.
[14] B. Mazières,et al. Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease , 1994, Clinical Rheumatology.
[15] E. Kurzrock,et al. Penile calciphylaxis: analysis of risk factors and mortality. , 2003, The Journal of urology.
[16] C. Wanner,et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study , 2003, The Lancet.
[17] C. Stehman-Breen,et al. Risk factors and mortality associated with calciphylaxis in end-stage renal disease. , 2001, Kidney international.
[18] M. McKee,et al. Phosphate regulation of vascular smooth muscle cell calcification. , 2000, Circulation research.
[19] J. Woosley,et al. Penile calciphylaxis: rare necrotic lesions in chronic renal failure patients. , 1998, The Journal of urology.
[20] G. Burg,et al. Calciphylaxis: a syndrome of skin necrosis and acral gangrene in chronic renal failure. , 1998, VASA. Zeitschrift fur Gefasskrankheiten.
[21] H. Selye,et al. Sensitization to calciphylaxis by endogenous parathyroid hormone. , 1962, Endocrinology.